Hepatitis News

 
 
Share this
 
 
Monday, February 3, 2014 - 14:31
Sample letter for medical providers for insurance company denial of treatment using two new FDA approved drugs to treat chronic hepatitis C, Olysio (simeprevir) and Sovaldi (sofosbuvir)
Monday, February 3, 2014 - 14:28
Read NVHR's letter to medical providers regarding the appeals process to appeal insurance company denial of treatment using two new FDA approved drugs to treat chronic hepatitis C, Olysio (simeprevir) and Sovaldi (sofosbuvir)
Wednesday, November 27, 2013 - 11:22
Martha Saly Leaving Executive Director Post at National Viral Hepatitis Roundtable
Wednesday, September 11, 2013 - 11:46
The Corporate Hepatitis Alliance (CHA)Presents “The Silent Epidemic” Understanding hepatitis C (HCV) and the crisis among African American Communities Thursday September 19th 4:00 PM to 5:30 PM
Wednesday, August 21, 2013 - 06:28
Read about the honorees and their accomplishments.